In August we added two startups to the Access portfolio, co-investing alongside one of our angel investors in each case (for more on our super angels and our co-investment model, see our [dedicated page](/invest/angel-investors)). Read on for more about our latest investments. If you would like to receive this update each month, [sign up for our newsletter here](/subscribe). ### Pencil Biosciences Pencil Biosciences is developing an innovative gene editing technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases. [](https://pencilbiosciences.com//) **Angel:** Our angel partner in the round has a weighted IRR of 34% and has previously invested in companies including Celixir, Sense Biodetection and Bank of Telecom. **Total Round:** approx. £700,000 [Visit website](https://pencilbiosciences.com/) ### Name currently witheld This company has created a network for employee referrals. They've asked us not to give any further details until their own press goes live. **Angel:** Our angel partner in the round has a weighted IRR of 32% and has previously invested in The Plum Guide, Plentific & Learnerbly **Total Round:** approx. £730,000. Find out more about how the Access EIS Fund can work for you. You can click the button below to schedule a call, or call us on 01223 478 558 and we'll be happy to answer any questions you might have. Schedule a call with us.